Showing results (41-50 of 57) with videos related to
Sort By:
Pageof 6
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 24, 2018
Marine ω-3 Polyunsaturated Fatty Acid and Fish Intake after Colon Cancer Diagnosis and Survival: CALGB 89803 (Alliance)Erin L Van Blarigan, Charles S Fuchs, Donna Niedzwiecki, et al.International Journal of Cancer|September 23, 2014
Potent antitumor activity of cabozantinib, a c-MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant modelEun-Kee Song, W M Tai, Wells A Messersmith, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2018
Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance)Temidayo Fadelu, Sui Zhang, Donna Niedzwiecki, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (Alliance)Brendan J Guercio, Kaori Sato, Donna Niedzwiecki, et al.Journal of the National Cancer Institute|March 18, 2021
BRAF V600E Mutation in First-Line Metastatic Colorectal Cancer: An Analysis of Individual Patient Data From the ARCAD DatabaseRomain Cohen, Heshan Liu, Jack Fiskum, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2023
Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048)Ethan Basch, Amylou C Dueck, Sandra A Mitchell, et al.JNCI Cancer Spectrum|June 8, 2018
Grain Intake and Clinical Outcome in Stage III Colon Cancer: Results From CALGB 89803 (Alliance)Justin C Brown, Sui Zhang, Donna Niedzwiecki, et al.JNCI Cancer Spectrum|June 9, 2021
Race, Income, and Survival in Stage III Colon Cancer: CALGB 89803 (Alliance)Seohyuk Lee, Sui Zhang, Chao Ma, et al.Nature Microbiology|September 22, 2022
Host and gut bacteria share metabolic pathways for anti-cancer drug metabolismPeter Spanogiannopoulos, Than S Kyaw, Ben G H Guthrie, et al.JAMA|April 6, 2021
Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical TrialJeffrey A Meyerhardt, Qian Shi, Charles S Fuchs, et al.Pageof 6